RS Research is developing novel nanomedicines based on innovative drug delivery platforms. Our expertise in targeted drug delivery helps bringing in added value for our partners through their R&D journey. Our know-how and infrastructure from pre-clinical studies to GMP production of oncological drugs can help you move your studies forward.
PRE-CLINICAL SERVICES
ADME
Preclinical ADME studies are designed to investigate the absorption, distribution, metabolism and excretion of novel pharmaceuticals to support lead candidate selection, preclinical testing and clinical development programs.
Available Studies:
- Bioavailability and pharmacokinetic (PK) studies
- Biodistribution studies
Toxicology
In vivo Toxicology is an application to determine the effect of systemic exposure of a compound in experimental animals (mice, rats, rabbits, guinea pigs, canines and non-human primates).
Available Studies:
- Toxicity Screening
- Acute Dose Toxicity Studies
- Chronic Toxicity Studies
- Safety pharmacology
BIOANALYTICAL & ANALYTICAL TESTING
Tests required for bio-equivalence studies and impurity analyses are provided. We can develop, validate and employ quantitative analytical methods for determination of pharmaceutical compounds ranging from small molecules to large proteins including bio-similars.
Services:
- Bioanalytical and Analytical Method Development and Validation
- Impurity and metabolite analysis
- Stability Testing
GMP
RS Research offers production of clinical batch-size products using full service GMP-compliant procedures and state-of-the-art equipment. We are specialized in the synthesis of investigational drugs; either biologic or small molecules destined for injectable dosage forms.
Our facility enables us to fill bulk liquid, including products that require aseptic liquid filling and lyophilization. These include: Cytotoxic, cytostatic and high potent APIs.
Our qualified team ensures a smooth interface between your early developmental activities and our formulation, analytical and production facilities.
